文献速递外周动脉疾病

血管内碎石辅助股腘动脉血运重建治疗严重钙化慢性肢体威胁性缺血:单中心中期结果

Intravascular Lithotripsy-Assisted Femoropopliteal Revascularization for Heavily Calcified Chronic Limb-Threatening Ischemia: Midterm Outcomes from a Single-Center Retrospective Study.
PubMed 文献 · Ann Vasc Surg · 2026-06-22

单中心回顾性研究纳入43例Rutherford 4-6级慢性肢体威胁性缺血患者,股腘动脉严重钙化(PACSS 3-4级),采用血管内碎石辅助药物涂层球囊血管成形术。24个月总生存率93.0%,一期通畅率和免于靶病变再干预率均为90.6%。

要点

  • 24个月一期通畅率和免于靶病变再干预率均为90.6%
  • 仅20.9%患者需补救性支架植入,选择性支架策略可行

核心结论

  • 在严重钙化和复杂解剖的CLTI探索性队列中,IVL辅助股腘动脉血运重建可行,选择性支架植入,中期通畅率和免于再干预率令人鼓舞。

研究设计与样本

  • 回顾性、单中心、单臂研究,纳入2023年6月至2025年4月连续43例Rutherford 4-6级CLTI患者。
  • 严重钙化定义为外周动脉钙化评分系统(PACSS)3级或4级。

主要发现

  • 平均年龄73.2±9.3岁,糖尿病34例(79.1%),慢性肾脏病21例(48.8%)。
  • 平均病变长度25.5±6.0 cm,慢性完全闭塞27例(62.8%),腘动脉受累18例(41.9%),TASC C/D病变38例(88.4%)。
  • PACSS 3级和4级钙化分别为19例(44.2%)和24例(55.8%)。
  • 技术成功全部病例,最终残余狭窄<30%,补救性支架植入9例(20.9%)。
  • 24个月Kaplan-Meier估计总生存率93.0%,一期通畅率和免于靶病变再干预率均为90.6%。

关键数值与推荐

  • 严重钙化定义为PACSS 3级或4级。
  • IVL用于药物涂层球囊血管成形术前的血管准备;补救性支架仅用于残余狭窄、回缩或限流性夹层。
  • 24个月总生存率93.0%,一期通畅率90.6%,免于靶病变再干预率90.6%。

临床怎么用

  • 对于严重钙化股腘动脉病变的CLTI患者,可考虑IVL辅助血管准备后行药物涂层球囊血管成形术。
  • 选择性支架植入策略(仅用于残余狭窄、回缩或限流性夹层)可行。
  • 中期随访显示良好的通畅率和免于再干预率,支持IVL在该复杂人群中的应用。

局限性

  • 回顾性、单中心、单臂设计,样本量小(43例),随访至24个月,为探索性结果。
  • 缺乏对照组,无法与其他血管准备技术直接比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate early and midterm outcomes of intravascular lithotripsy (IVL)-assisted endovascular treatment for severely calcified femoropopliteal disease in patients with chronic limb-threatening ischemia (CLTI). METHODS: This retrospective, single-center, single-arm study included 43 consecutive Rutherford class 4-6 CLTI patients treated between June 2023 and April 2025. Severe calcification was defined as Peripheral Arterial Calcium Scoring System grade 3 or 4. IVL was used for vessel preparation before drug-coated balloon angioplasty; adjunctive stenting was reserved for residual stenosis, recoil, or flow-limiting dissection. Overall survival, primary patency, and freedom from target-lesion reintervention were estimated using Kaplan-Meier analysis. RESULTS: The mean age was 73.2 ± 9.3 years; 34 patients (79.1%) had diabetes and 21 (48.8%) had chronic kidney disease. The mean lesion length was 25.5 ± 6.0 cm. Chronic total occlusions were present in 27 patients (62.8%), popliteal involvement in 18 (41.9%), and TransAtlantic Inter-Society Consensus C/D disease in 38 (88.4%). Peripheral Arterial Calcium Scoring System grade 3 and 4 calcification were present in 19 (44.2%) and 24 (55.8%) patients, respectively. Technical success was achieved in all cases, with final residual stenosis <30%. Bailout stenting was required in 9 patients (20.9%). At 24 months, Kaplan-Meier estimates were 93.0% for overall survival and 90.6% for both primary patency and freedom from target-lesion reintervention. CONCLUSION: In this exploratory CLTI cohort, IVL-assisted femoropopliteal revascularization was feasible despite severe calcification and complex anatomy, with selective stenting and encouraging midterm patency and freedom from reintervention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Domenico M, Manfredi Agostino M, Chiara F, et al. Intravascular Lithotripsy-Assisted Femoropopliteal Revascularization for Heavily Calcified Chronic Limb-Threatening Ischemia: Midterm Outcomes from a Single-Center Retrospective Study. Ann Vasc Surg. 2026. PMID: 42331217. doi:10.1016/j.avsg.2026.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。